Edwards Larry Todd - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 17, 2024, Edwards Larry Todd's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Officer (SVP Chief Commercial Officer), and currently has 140,360 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ARQT insiders.
Data Source: SEC.
Edwards Larry Todd - Insider Non-Derivative Transactions of ARQT Common Stock
Edwards Larry Todd - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
May 18, 2024 | Sell -- (Common Stock) | 7640 | 8.98 | 140360 |
May 17, 2024 | Acquisition -- (Common Stock) | 60000 | 0 | 148000 |
Jan 13, 2024 | Acquisition -- (Common Stock) | 28000 | 0 | 88000 |
Sep 28, 2023 | Acquisition -- (Common Stock) | 60000 | 0 | 60000 |